Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma
Authors
Keywords
Clear-cell ovarian carcinoma, <em class=EmphasisTypeItalic >KRAS</em>, <em class=EmphasisTypeItalic >NRAS</em>, <em class=EmphasisTypeItalic >BRAF</em>, Hot spot mutations
Journal
VIRCHOWS ARCHIV
Volume 465, Issue 2, Pages 193-198
Publisher
Springer Nature
Online
2014-06-03
DOI
10.1007/s00428-014-1599-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epithelial Ovarian Cancer
- (2014) Evelyn Despierre et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants
- (2013) Sabine Heublein et al. BMC CANCER
- Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer
- (2013) Björn Nodin et al. Diagnostic Pathology
- TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type
- (2013) Markus Rechsteiner et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Comprehensive genomic profiling of epithelial ovarian cancer by next generation sequencing-based diagnostic assay reveals new routes to targeted therapies
- (2013) J.S. Ross et al. GYNECOLOGIC ONCOLOGY
- KRAS(but notBRAF) mutations in ovarian serous borderline tumour are associated with recurrent low-grade serous carcinoma
- (2013) Yvonne T Tsang et al. JOURNAL OF PATHOLOGY
- Mutational analysis ofBRAFandKRASin ovarian serous borderline (atypical proliferative) tumours and associated peritoneal implants
- (2013) Laura Ardighieri et al. JOURNAL OF PATHOLOGY
- Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy
- (2013) Ren-Chin Wu et al. JOURNAL OF PATHOLOGY
- Prognostic determinants in patients with uterine and ovarian clear carcinoma
- (2012) J. Alejandro Rauh-Hain et al. GYNECOLOGIC ONCOLOGY
- Clinicopathologic and Immunohistochemical Features of Ovarian Clear Cell Carcinomas in Comparison With Type I and Type II Tumors
- (2012) Gian Franco Zannoni et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Ovarian clear cell carcinoma as a stress-responsive cancer: Influence of the microenvironment on the carcinogenesis and cancer phenotype
- (2011) Masaki Mandai et al. CANCER LETTERS
- Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010
- (2011) Michael S. Anglesio et al. GYNECOLOGIC ONCOLOGY
- The influence of KRAS and BRAF mutations on the efficacy of cetuximab-based first-line therapy of metastatic colorectal cancer: An analysis of the AIO KRK-0104-trial
- (2011) D.P. Modest et al. INTERNATIONAL JOURNAL OF CANCER
- BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
- (2010) Kwong-Kwok Wong et al. AMERICAN JOURNAL OF PATHOLOGY
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- The biological and clinical value of p53 expression in pelvic high-grade serous carcinomas
- (2010) Martin Köbel et al. JOURNAL OF PATHOLOGY
- Identification of an ovarian clear cell carcinoma gene signature that reflects inherent disease biology and the carcinogenic processes
- (2010) K Yamaguchi et al. ONCOGENE
- Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
- (2010) Siân Jones et al. SCIENCE
- Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma
- (2009) Kuan-Ting Kuo et al. AMERICAN JOURNAL OF PATHOLOGY
- KRAS mutation analysis in ovarian samples using a high sensitivity biochip assay
- (2009) Veronika Auner et al. BMC CANCER
- Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer
- (2009) Jens Neumann et al. PATHOLOGY RESEARCH AND PRACTICE
- Ovarian Cancer
- (2008) Kathleen R. Cho et al. Annual Review of Pathology-Mechanisms of Disease
- Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma
- (2008) Hiroaki Itamochi et al. CANCER SCIENCE
- Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers
- (2008) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
- Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance
- (2007) R. SALANI et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now